NNNaima Ghailani Nourouti

Naima Ghailani Nourouti

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Naima Ghailani Nourouti has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The role of gut microbiome in obesity and metabolic dysfunctions: Insights and therapeutic potential

    by Siham El Moussaoui, Touria Derkaoui, Fatima Zahrae Alaoui Ismaili, Nezha Tawfiq, Mohammed El Mzibri, Abdelilah Laraqui, Mohamed Mansouri, Amina Barakat, Naima Ghailani Nourouti, Maria Paz Weisshaar, et al.

    Obesity is a chronic inflammatory disease defined by an excessive accumulation of body fat. The human gut microbiota (GM) is an intricate ecosystem of microorganisms living symbiotically within the gastrointestinal tract and has emerged as a key player in health and metabolic diseases. Recently, several studies have increasingly revolved around understanding the specific compositions and strains of GM and their potential impact on obesity. This review provides a summary of the most recent findings regarding obesity and newly developed therapies that show exceptional efficacy in treating this condition. In addition, it explores different GM strains that may contribute to the progression and development of obesity. This article summarizes the molecular insights involved in the relationship between obesity and GM, the characteristics of this ecosystem, and its involvement in human metabolism, energy balance, and inflammation leading to obesity. Furthermore, it examines the bacteria most engaged in managing obesity. These findings contribute to a better understanding of this significant and intricate relationship, ultimately aiding in obesity prevention.


  • Open Access

    Moroccan eating habits during COVID-19 lockdown: a preliminary analysis

    by Zeineb Zian, Assia Bouhoudan, Joaira Bakkach, Nadira Mourabit, Amina Barakat, Naima Ghailani Nourouti, Mohcine Bennani Mechita, Elsa Lamy

  • XmnI Polymorphism in Sickle Cell Disease in North Morocco

    by Fatima-Zahra Alaoui-Ismaili, Achraf Laghmich, Naima Ghailani-Nourouti, Amina Barakat, Mohcine Bennani-Mechita

    Sickle cell disease is one of the most common severe monogenic disorders in the world. The –158 XmnI polymorphism (C>T) of the Gγ-globin gene promoter is known to be associated with increased expression of the Gγ-globin gene, thus, higher production of Hb F and lesser clinical severity. This study aims to determine the frequency of the XmnI polymorphism and its association with Hb F levels as a modulating factor of sickle cell disease severity in north Moroccan patients. Three hundred and eight subjects carrying the sickle cell mutation and 160 healthy individuals were recruited at the regional hospital of Larache, Morocco. The complete blood count and the Hb F levels were analyzed. The XmnI polymorphism was determined by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique and statistical analysis were done using the Statistical Package for Social Sciences software version 20. Our results estimated the allelic frequency of the XmnI polymorphism in our population at 15.8%. Out of 468 samples, 7.6% were homozygous [+/+] and 16.4% were heterozygous [+/−] for the XmnI polymorphism. This polymorphism was revealed at 20.6% in SS patients, 24.2% in AS carriers, 28.6% in Hb S (HBB: c.20A>T)/β-thalassemia (β-thal) patients and 22.5% in AA subjects. The north Moroccan sickle cell disease patients have shown a low frequency of the XmnI polymorphism. This was later found to be associated with high Hb F levels and mild clinical severity.